Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK Modeling

NCT02435563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: ticagrelor 180 mg administrated alone
DRUG: Ticagrelor adjusted dose + ritonavir 100mg

Sponsor

University Hospital, Geneva